China News Service, May 19, according to US media reports, on the 18th local time, US President Trump said he had been taking the antimalarial drug hydroxychloroquine (hydroxychloroquine) for more than a week to prevent infection with the new crown virus. However, the effectiveness of this drug has not been confirmed.
Recently, due to multiple officials and secret agents diagnosed with the new crown virus, the White House issued new guidelines on May 11 requiring employees to wear masks when working in the West Wing of the White House. However, this rule still does not include Trump.
According to reports, Trump said at the White House roundtable: "I happen to be eating." "There are already many good things happening. You will be surprised that so many people are taking it, especially the frontline staff." He Added: "I am taking hydroxychloroquine. Now, yes. I started taking it a few weeks ago. Because I think it's good, I have heard many good stories."
Trump also claimed that he received "a lot of very positive news" about the drug. He does not hold stock in the company that produces the drug. He hoped that "the people of this country feel good".
Hydroxychloroquine is often used by doctors to treat rheumatoid arthritis and other diseases. Many clinical trials are observing whether it can effectively fight the new coronavirus, but it has not been confirmed. US Consumer News and Business Channel said it has serious side effects, including muscle weakness and arrhythmia.
Trump has repeatedly recommended hydroxychloroquine drugs at the White House conference, causing a lot of controversy. Fuch, the director of the National Institute of Allergy and Infectious Diseases, once said that although there is some evidence that hydroxychloroquine may benefit new crown patients, more reliable data from large-scale randomized controlled clinical trials are needed to determine this treatment Is it safe and can it improve clinical outcomes.
Earlier, the US Food and Drug Administration (FDA) warned new crown patients not to use chloroquine or hydroxychloroquine for treatment outside hospitals or formal clinical trials.
A study published in the United States "New England Journal of Medicine" earlier this month showed that there is no evidence that hydroxychloroquine is helpful for the treatment of new crown hospitalized patients.